Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nordhealth As | Oslo | Salute | Attrezzature e forniture medicali | 3,43 Mrd NOK | -30,9x | 43,40 NOK | 8,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 6,7% Rialzo | Fai l’upgrade a Pro+ | ||
Medistim | Oslo | Salute | Attrezzature e forniture medicali | 2,72 Mrd NOK | 27x | -2 | 148,50 NOK | 0,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 15,8% Rialzo | Fai l’upgrade a Pro+ | |
Photocure | Oslo | Salute | Prodotti farmaceutici | 1,46 Mrd NOK | 102,9x | 0,73 | 53,90 NOK | -3,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Vistin Pharma ASA | Oslo | Salute | Prodotti farmaceutici | 1 Mrd NOK | 16,4x | 0,43 | 22,60 NOK | -2,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Nykode Therapeutics | Oslo | Salute | Ricerca medica e biotecnologica | 877,10 Mln NOK | -1,9x | -0,3 | 2,69 NOK | 2,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Arcticzymes Tech | Oslo | Salute | Ricerca medica e biotecnologica | 715 Mln NOK | 162,1x | -1,97 | 14 NOK | -1,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 14,3% Rialzo | Fai l’upgrade a Pro+ | |
Omda AS | Oslo | Salute | Attrezzature e forniture medicali | 680,06 Mln NOK | -21,5x | 0,16 | 33,70 NOK | 3,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 30,6% Rialzo | Fai l’upgrade a Pro+ | |
Gentian Diagnostics | Oslo | Salute | Attrezzature e forniture medicali | 623,06 Mln NOK | 280,6x | 1,97 | 40,40 NOK | 0,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Thor Medical | Oslo | Salute | Ricerca medica e biotecnologica | 622,38 Mln NOK | -47x | 2,65 NOK | 1,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
Navamedic | Oslo | Salute | Prodotti farmaceutici | 450,40 Mln NOK | 16,5x | 25,50 NOK | 4,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 45,1% Rialzo | Fai l’upgrade a Pro+ | ||
ContextVision AB | Oslo | Salute | Attrezzature e forniture medicali | 416,24 Mln NOK | 18,2x | -0,45 | 5,38 NOK | 1,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 11,5% Rialzo | Fai l’upgrade a Pro+ | |
Bergenbio | Oslo | Salute | Ricerca medica e biotecnologica | 334,43 Mln NOK | -1,8x | -0,03 | 8,56 NOK | 0,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Lytix Biopharma AS | Oslo | Salute | Ricerca medica e biotecnologica | 284,76 Mln NOK | 5,74 NOK | -0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||||
Lifecare | Oslo | Salute | Ricerca medica e biotecnologica | 210,04 Mln NOK | -2,9x | 0,46 | 13,25 NOK | -5,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
INIFY Laboratories | Oslo | Salute | Attrezzature e forniture medicali | 203,57 Mln NOK | 4,50 NOK | -6,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||||
Exact Therapeutics AS | Oslo | Salute | Ricerca medica e biotecnologica | 109,07 Mln NOK | -3,5x | 0,05 | 3,40 NOK | -1,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Observe Medical | Oslo | Salute | Attrezzature e forniture medicali | 105,90 Mln NOK | -1x | -0,03 | 5,50 NOK | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Arctic Bioscience AS | Oslo | Salute | Prodotti farmaceutici | 74,59 Mln NOK | -7,2x | 0,08 | 2,94 NOK | 8,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Ultimovacs | Oslo | Salute | Ricerca medica e biotecnologica | 73,63 Mln NOK | -0,6x | -0,02 | 2,14 NOK | 1,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Circio Holding | Oslo | Salute | Ricerca medica e biotecnologica | 57,15 Mln NOK | 0,6x | 0,06 | 0,70 NOK | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
PCI Biotech | Oslo | Salute | Ricerca medica e biotecnologica | 48,30 Mln NOK | -3x | -0,07 | 1,29 NOK | 3,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
SoftOx Solutions | Oslo | Salute | Ricerca medica e biotecnologica | 25,37 Mln NOK | 0,010 NOK | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||||
Codelab Capital AS | Oslo | Salute | Attrezzature e forniture medicali | 20,99 Mln NOK | 0,06 NOK | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |